SynthesisArchives of orthopaedic and trauma surgery2025
Bony increased offset reverse shoulder arthroplasty (BIO-RSA) vs metal augments: A systematic review.
Synthesis in Archives of orthopaedic and trauma surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The «SPA-CE» classification for glenoid bone loss in reverse shoulder arthroplasty: a CT-based analysis of 211 shoulders.Musculoskeletal surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionLateralisation in reverse shoulder arthroplasty can be achieved through bone graft (BIO-RSA) or metal augments (MIO-RSA). This systematic review and meta-analysis aimed to compare outcomes in both these methods. MATERIALS AND
methodsA systematic review of Pubmed, Cochrane, Medline and EMBASE was performed including all studies on primary reverse total shoulder replacements with lateralised glenoid components using either bone graft (BIO-RSA) or metal augments (MIO-RSA). Collected data for included studies included demographics, method of lateralisation and complications.
results30 studies comprising 2364 shoulders in 2558 patients were included, with a mean age of 72.8 (23-93), and 59.7% being female. 1026 patients underwent BIO-RSA and 1328 underwent arthroplasty with metal augmented glenoid components. After 31.5 months (3-126) follow-up, there was a significantly lower pain score (p < 0.05) and higher ASES (p < 0.05) and UCLA (p < 0.05) scores in patients post MIO-RSA, but no significant difference in range of movement post-operatively. Moreover, there was lower rates of revisions (1.3% v 3.0%, p < 0.01), loosening (0.8% v 2.4%, p < 0.01) and scapular notching (3.8% v 17.3%, p < 0.01) in the MIO-RSA group.
conclusionsBIO-RSA and MIO-RSA outcomes are summarised, suggesting preliminary evidence of some superiority of MIO-RSA, but heterogeneity in the selected studies limits the conclusions that can be drawn from results. Long term studies are required to ascertain if this effect is maintained.
Indexed as
Identifiers
40465002What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.